Perspectives for immunotherapy: which applications might achieve an HIV functional cure?
about
Neutralizing Antibodies Against a Specific Human Immunodeficiency Virus gp41 Epitope are Associated With Long-term Non-progressor Status.Immunomodulatory Therapy of Visceral Leishmaniasis in Human Immunodeficiency Virus-Coinfected Patients.The Hard Way towards an Antibody-Based HIV-1 Env Vaccine: Lessons from Other Viruses.
P2860
Perspectives for immunotherapy: which applications might achieve an HIV functional cure?
description
2016 nî lūn-bûn
@nan
2016 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Perspectives for immunotherapy: which applications might achieve an HIV functional cure?
@ast
Perspectives for immunotherapy: which applications might achieve an HIV functional cure?
@en
Perspectives for immunotherapy: which applications might achieve an HIV functional cure?
@nl
type
label
Perspectives for immunotherapy: which applications might achieve an HIV functional cure?
@ast
Perspectives for immunotherapy: which applications might achieve an HIV functional cure?
@en
Perspectives for immunotherapy: which applications might achieve an HIV functional cure?
@nl
prefLabel
Perspectives for immunotherapy: which applications might achieve an HIV functional cure?
@ast
Perspectives for immunotherapy: which applications might achieve an HIV functional cure?
@en
Perspectives for immunotherapy: which applications might achieve an HIV functional cure?
@nl
P2093
P2860
P921
P356
P1433
P1476
Perspectives for immunotherapy: which applications might achieve an HIV functional cure?
@en
P2093
Brigitte Autran
Christine Katlama
Joël Crouzet
Odile Launay
Patrice Debré
Raphael Ho Tsong Fang
Robert L Murphy
Shahin Gharakhanian
Vincent Vieillard
P2860
P304
38946-38958
P356
10.18632/ONCOTARGET.7793
P407
P5008
P577
2016-06-21T00:00:00Z